OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming
Jack Green, Yu Shi, Fatima Martín‐Sánchez, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 40
Open Access | Times Cited: 167

Showing 1-25 of 167 citing articles:

The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Karen V. Swanson, Meng Deng, Jenny P.‐Y. Ting
Nature reviews. Immunology (2019) Vol. 19, Iss. 8, pp. 477-489
Open Access | Times Cited: 3550

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
Nathan Kelley, Devon Jeltema, Yanhui Duan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3328-3328
Open Access | Times Cited: 2712

Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang Yang, Huanan Wang, Mohammed Kouadir, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 2
Open Access | Times Cited: 1063

An update on the regulatory mechanisms of NLRP3 inflammasome activation
Seungwha Paik, Jin Kyung Kim, Prashanta Silwal, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 5, pp. 1141-1160
Open Access | Times Cited: 539

Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation
Jianing Fu, Hao Wu
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 301-316
Open Access | Times Cited: 529

The NLRP3 inflammasome: activation and regulation
Jie Xu, Gabriel Núñez
Trends in Biochemical Sciences (2022) Vol. 48, Iss. 4, pp. 331-344
Closed Access | Times Cited: 286

Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway
Jing Zhang, Lelin Huang, Xingming Shi, et al.
Aging (2020) Vol. 12, Iss. 23, pp. 24270-24287
Open Access | Times Cited: 207

Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3
Inga V. Hochheiser, Michael Pilsl, Gregor Hagelueken, et al.
Nature (2022) Vol. 604, Iss. 7904, pp. 184-189
Open Access | Times Cited: 197

The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target
William T. O’Brien, Louise Pham, Georgia F. Symons, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 175

How location and cellular signaling combine to activate the NLRP3 inflammasome
Anil Akbal, Alesja Dernst, Marta Lovotti, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 11, pp. 1201-1214
Open Access | Times Cited: 133

The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies
Ni Zhao, Bin Di, Lili Xu
Cytokine & Growth Factor Reviews (2021) Vol. 61, pp. 2-15
Open Access | Times Cited: 127

Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome
Hao Li, Yanling Guan, Bo Liang, et al.
European Journal of Pharmacology (2022) Vol. 928, pp. 175091-175091
Closed Access | Times Cited: 106

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
Xiaoyan Zhan, Qiang Li, Guang Xu, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 88

The role of inflammasomes in human diseases and their potential as therapeutic targets
Jing Yao, Keenan Sterling, Zhe Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73

The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy
Xiaoqin Zheng, Jia Wan, Gang Tan
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 57

NLRP inflammasomes in health and disease
Zhihao Xu, Arnaud John Kombe Kombe, Shasha Deng, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 29

NLRP3 inflammasome in health and disease (Review)
Haoran Wang, Li Ma, Weiran Su, et al.
International Journal of Molecular Medicine (2025) Vol. 55, Iss. 3
Closed Access | Times Cited: 2

Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review
Danbin Wu, Yefei Chen, Yingxin Sun, et al.
Inflammation (2019) Vol. 43, Iss. 1, pp. 17-23
Closed Access | Times Cited: 125

Role of inflammasomes in the pathogenesis of periodontal disease and therapeutics
Julie T. Marchesan, Mustafa Girnary, Kevin Moss, et al.
Periodontology 2000 (2019) Vol. 82, Iss. 1, pp. 93-114
Open Access | Times Cited: 125

Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro
Anna Gritsenko, Yu Shi, Fatima Martín‐Sánchez, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 122

ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis
Thomas Scambler, Heledd Jarosz-Griffiths, Samuel Lara‐Reyna, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 91

Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases
Jin Kyung Seok, Han Chang Kang, Yong‐Yeon Cho, et al.
Archives of Pharmacal Research (2021) Vol. 44, Iss. 1, pp. 16-35
Open Access | Times Cited: 88

The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout
Zoltán Szekanecz, Szilvia Szamosi, Gergő Kovács, et al.
Archives of Biochemistry and Biophysics (2019) Vol. 670, pp. 82-93
Closed Access | Times Cited: 77

Recent insights into the regulatory networks of NLRP3 inflammasome activation
Alexander N.R. Weber, Zsofia Bittner, Sangeetha Shankar, et al.
Journal of Cell Science (2020) Vol. 133, Iss. 23
Open Access | Times Cited: 73

Page 1 - Next Page

Scroll to top